Evaluation of no evidence of progression using composite outcome measures, in patients with primary progressive multiple sclerosis in the ORATORIO trial

X. Montalban, D. L. Arnold, A. Bar-Or, J. De Séze, G. Giovannoni, B. Hammer, K. Rammohan, D. Masterman, C. Barnasconi, W. Wei, S. Belachew, P. Chin, J. Wolinski, The ORATORIO clinical investigators , Egon Stenager (Medlem af forfattergruppering)

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
Artikelnummer167
TidsskriftMultiple Sclerosis Journal
Vol/bind22
Udgave nummerSuppl. 3
Sider (fra-til)50
Antal sider1
ISSN1352-4585
DOI
StatusUdgivet - sep. 2016
Begivenhed32nd ECTRIMS: Congress of the European Committee for Treatment and Research in Multiple Sclerosis - ExCeL London, London, Storbritannien
Varighed: 14. sep. 201617. sep. 2016

Konference

Konference32nd ECTRIMS
LokationExCeL London
LandStorbritannien
ByLondon
Periode14/09/201617/09/2016

Citationsformater

Montalban, X., Arnold, D. L., Bar-Or, A., De Séze, J., Giovannoni, G., Hammer, B., Rammohan, K., Masterman, D., Barnasconi, C., Wei, W., Belachew, S., Chin, P., Wolinski, J., The ORATORIO clinical investigators , & Stenager, E. (2016). Evaluation of no evidence of progression using composite outcome measures, in patients with primary progressive multiple sclerosis in the ORATORIO trial. Multiple Sclerosis Journal, 22(Suppl. 3), 50. [167]. https://doi.org/10.1177/1352458516663068